ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko03040	Spliceosome	55/335	145/7206	6.97639314874e-37
ko03008	Ribosome biogenesis in eukaryotes	31/335	79/7206	1.44885687739e-21
ko04110	Cell cycle	36/335	145/7206	2.6254510671e-17
ko04111	Cell cycle - yeast	26/335	90/7206	1.66752639617e-14
ko03013	RNA transport	33/335	166/7206	5.81768978863e-13
ko03460	Fanconi anemia pathway	16/335	51/7206	5.42726229139e-10
ko03030	DNA replication	14/335	38/7206	5.90317850007e-10
ko04113	Meiosis - yeast	17/335	70/7206	1.22580322587e-08
ko03440	Homologous recombination	13/335	41/7206	2.03387613501e-08
ko03410	Base excision repair	12/335	38/7206	7.60501654719e-08
ko00240	Pyrimidine metabolism	19/335	110/7206	5.78260209249e-07
ko03430	Mismatch repair	8/335	22/7206	3.62102042522e-06
ko04144	Endocytosis	2/335	342/7206	1.71354991158e-05
ko03015	mRNA surveillance pathway	15/335	93/7206	2.14460004422e-05
ko04151	PI3K-Akt signaling pathway	4/335	390/7206	9.45794472843e-05
ko03018	RNA degradation	13/335	84/7206	0.00011776473731
ko03420	Nucleotide excision repair	9/335	46/7206	0.000218123443517
ko03020	RNA polymerase	7/335	29/7206	0.000283356775789
ko04810	Regulation of actin cytoskeleton	2/335	264/7206	0.000500579724359
ko04261	Adrenergic signaling in cardiomyocytes	1/335	205/7206	0.00108674281043
ko04024	cAMP signaling pathway	3/335	279/7206	0.00127377894544
ko04014	Ras signaling pathway	3/335	279/7206	0.00127377894544
ko05166	HTLV-I infection	26/335	292/7206	0.00147895360041
ko04510	Focal adhesion	2/335	240/7206	0.00150747244191
ko04072	Phospholipase D signaling pathway	1/335	197/7206	0.00159670220845
ko05205	Proteoglycans in cancer	3/335	271/7206	0.00180106262798
ko04114	Oocyte meiosis	15/335	139/7206	0.0019243068338
ko04530	Tight junction	2/335	228/7206	0.00213599331303
ko04728	Dopaminergic synapse	1/335	185/7206	0.00229245356316
ko05152	Tuberculosis	1/335	187/7206	0.0023059967987
ko04060	Cytokine-cytokine receptor interaction	1/335	191/7206	0.00240718997696
ko04371	Apelin signaling pathway	1/335	177/7206	0.00334417719096
ko03022	Basal transcription factors	7/335	44/7206	0.00382134982173
ko04022	cGMP-PKG signaling pathway	2/335	216/7206	0.0044918729968
ko04723	Retrograde endocannabinoid signaling	1/335	175/7206	0.00519480301883
ko04015	Rap1 signaling pathway	4/335	278/7206	0.00537495110746
ko04921	Oxytocin signaling pathway	2/335	209/7206	0.00652859473419
ko04725	Cholinergic synapse	1/335	160/7206	0.00707492905995
ko04145	Phagosome	1/335	162/7206	0.00714137974729
ko04360	Axon guidance	3/335	233/7206	0.0101494972093
ko04724	Glutamatergic synapse	1/335	152/7206	0.0102799152301
ko05012	Parkinson's disease	1/335	155/7206	0.0105034445686
ko04120	Ubiquitin mediated proteolysis	13/335	138/7206	0.0129784283899
ko00230	Purine metabolism	17/335	194/7206	0.0135970097329
ko04010	MAPK signaling pathway	6/335	321/7206	0.0136453865617
ko04217	Necroptosis	2/335	178/7206	0.0177018382561
ko04115	p53 signaling pathway	8/335	74/7206	0.0208907485453
ko04380	Osteoclast differentiation	1/335	134/7206	0.0214554245375
ko05231	Choline metabolism in cancer	1/335	134/7206	0.0214554245375
ko04933	AGE-RAGE signaling pathway in diabetic complications	1/335	135/7206	0.0215216797628
ko04713	Circadian entrainment	1/335	136/7206	0.0216350682922
ko04726	Serotonergic synapse	1/335	137/7206	0.0217956514389
ko04218	Cellular senescence	15/335	177/7206	0.0271106120533
ko04914	Progesterone-mediated oocyte maturation	10/335	104/7206	0.0291117356362
ko05145	Toxoplasmosis	1/335	126/7206	0.0309863686437
ko04540	Gap junction	1/335	128/7206	0.0313269830087
ko05142	Chagas disease (American trypanosomiasis)	1/335	130/7206	0.0319265629011
ko04915	Estrogen signaling pathway	1/335	131/7206	0.032323465426
ko04722	Neurotrophin signaling pathway	2/335	160/7206	0.0348749316618
ko04071	Sphingolipid signaling pathway	2/335	162/7206	0.0352669270633
ko04611	Platelet activation	2/335	163/7206	0.0355466645648
ko05169	Epstein-Barr virus infection	16/335	206/7206	0.0416909020857
ko04911	Insulin secretion	1/335	117/7206	0.0445251038874
ko04666	Fc gamma R-mediated phagocytosis	1/335	122/7206	0.0462372969685
ko04932	Non-alcoholic fatty liver disease (NAFLD)	3/335	182/7206	0.0488458751981
ko05160	Hepatitis C	2/335	153/7206	0.0492140147739